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Background: Newborns with hypoplastic left heart 
syndrome (HLHS) or right heart syndrome or other 
malformations with a single ventricle physiology and 
associated hypoplasia of the great arteries continue to 
be a challenge in terms of survival. The vast majority of 
these forms of congenital heart defects relate to abnormal 
morphogenesis during early intrauterine development and 
can be diagnosed accurately by fetal echocardiography. 
Early knowledge of these conditions not only permits 
a better understanding of the progression of these 
malformations but encourages some researchers to explore 
new minimally invasive therapeutic options with a view to 
early pre- and postnatal cardiac palliation. 
Data sources: PubMed database was searched 
with terms of "congenital heart defects", "fetal 
echocardiography" and "neonatal cardiac surgery". 
Results: At present, early prenatal detection has been 
applied for monitoring pregnancy to avoid intrauterine 
cardiac decompensation. In principle, the majority of 
congenital heart defects can be diagnosed by prenatal 
echocardiography and the detection rate is 85%-95% at 
tertiary perinatal centers. The majority, particularly of 
complex congenital lesions, show a steadily progressive 
course including subsequent secondary phenomena 
such as arrhythmias or myocardial insuffi ciency. So 
prenatal treatment of an abnormal fetus is an area of 
perinatal medicine that is undergoing a very dynamic 
development. Early postnatal treatment is established for 
some time, and prenatal intervention or palliation is at its 
best experimental stage in individual cases.
Conclusion: The upcoming expansion of fetal 
cardiac intervention to ameliorate critically progressive 
fetal lesions intensifi es the need to address issues about 
the adequacy of technological assessment and patient 
selection as well as the morbidity of those who undergo 
these procedures. 
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Introduction
Heart defects are among the most common congenital 
malformations and the reported incidence is 0.5%-1% 
for all neonates. About half of these cardiovascular 
malformations are severe and usually require one 
or more surgical procedures in the neonatal period 
or during childhood.[1-10] In Switzerland, every 
pregnant woman is entitled to two routine ultrasound 
scans by her obstetrician as part of routine prenatal 
care.[11-13] Besides determining fetal growth and 
the development of pregnancy, the function of the 
second and increasingly of the fi rst scan is to identify 
malformations in the fetus.[14-19] However, international 
and national prospective studies of prenatal "screening 
for heart defects" show that, up to now only 10%-30% 
of all cardiac defects or 20%-50% of discoverable 
cardiac lesions using the "four-chamber" ultrasound 
screening are actually diagnosed prenatally.[10,17-38]
If the neonatal mortality fi gures are considered in 
detail, it is striking that about 20% of all infant deaths 
and therefore 50% of these deaths can still be attributed 
to congenital heart disease or cardiovascular malfor-
mations.[11,18,19,33,34,39,40] Interdisciplinary collaboration 
between neonatology, obstetric and prenatal medicine, 
pediatric cardiology, pediatric cardiac surgery and 
human genetics is essential to improve the baseline 
for perinatal treatment of these neonates, who are 
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sometimes born seriously ill. If a heart defect has 
already been diagnosed prenatally, the infant with 
heart disease can usually be born spontaneously in 
the relevant perinatal or cardiac pediatric center and 
be treated and cared for without delay in the affi liated 
departments, thus avoiding a potentially hazardous 
postnatal transport. In many cases early interventional 
and/or surgical treatment is important for improving 
the prognosis of the neonate with heart disease besides 
using intensive care and medication.[10,11,18-20,23,27,35,36]
Several large studies have confi rmed that not 
only perinatal management but also mortality and 
postoperative morbidity of affected newborns are 
markedly improved by the prenatal discovery of a 
transposition of the great vessels or hypoplastic left 
heart syndrome for example.[3,9,18,19,40-45] Moreover, it is 
increasingly postulated that the postnatal treatment of 
cardiac malformations diagnosed in utero is delayed 
because morphological causes of these conditions (e.g., 
valve stenosis or dysplasia) can lead to, sometimes 
irreversible, secondary damage to sections of the heart 
and vessels without a primary malformation because 
intracardiac and intravascular hemodynamics are 
altered during the course of fetal growth compared 
to extra-uterine conditions.[4,6,12,13,18,19,25-27,30,37,45] It is 
evident that these ideas about the genesis and prenatal 
progression of congenital heart malformations will 
have a crucial infl uence on future treatment plans. 
Discussion of possible developments in the next few 
years in the area of intrauterine treatment of certain 
obstructive heart defects may appear speculative at 
present.[4-6,12,13,18,19,25-27,30,37,45,46] Nevertheless, this article 
presents an early compressed and critical picture not 
only of current prenatal diagnostic and counselling 
possibilities but also of the fi rst in utero case histories.
Indications and limitations of prenatal 
cardiac diagnosis
The problem of referral for specialized fetal echocardio-
graphy to screen for or confi rm the diagnosis of 
congenital heart malformations is closely linked to 
the recognition of possible risk factors. In only about 
10%-30% of fetuses with cardiac lesions, there are 
case-history related or (molecular) genetic risks (family 
history, teratogens in early pregnancy, maternal 
disease, new mutations detectable by molecular 
genetics).[16,18,19,21,22,32,34,35,37] Since a risk factor can 
currently not be elicited either from the history or with 
conventional genetic or molecular genetic methods 
in 70%-90% of congenital heart defects, sonographic 
"abnormalities" on obstetric ultrasound screening 
during prenatal care point the way to effective use of 
the expertise available in pre- and perinatal centers. 
About 40%-50% of congenital heart defects can be 
discovered with just the four-chamber view in a low-
risk population, and additional examination of the 
outfl ow tracts and the two great arteries increases this 
rate to 65%-70% and encompasses all critical cardiac 
defects.[17-20,33,34,36,37] However, this potential is currently 
by no means reached. In surveys of diagnosed 
malformations, congenital heart defects are markedly 
underrepresented compared with malformations 
of other organs, as they usually elude prenatal 
diagnosis.[10,11,16-20,24,28,33,36,38,40,47,48] This may be due 
to interpretation of the scans of the heart taken from 
various angles, which demands good spatial awareness 
on the part of the examiner, and the assessment of even 
an optimal four-chamber view is highly dependent on 
the examiner's level of training. Diagnostic imaging of 
the fetal heart, as in all ultrasound imaging, depends 
greatly on the structure and extent of the overlying 
layers of maternal and fetal tissues. It is crucially 
important to record all malformations prenatally as 
exactly as possible, particularly in fetuses in which 
additional extracardiac malformations are found during 
prenatal investigations. If co-existing chromosome 
abnormalities are found, further stressful diagnostic 
measures or measures to prolong the pregnancy can 
be omitted because of the associated and sometimes 
substantial worsening of the fetal prognosis. 
A growing group of patients who should be referred 
for more intensive prenatal diagnosis consists of those 
who deliberately forego chromosome testing (e.g., by 
amniocentesis or chorionic villus biopsy) because of the 
low risk of abortion despite the presence of an indication. 
Precisely in this group, defi nite ultrasonic exclusion of 
a fetal cardiac lesion is more important since a heart 
defect is present in approximately 50% of neonates 
with trisomy 21, approximately 99% with trisomy 18, 
approximately 90% with trisomy 13 and in 35% of 
fetuses with Noonan's syndrome.[18,19,20-22,28,33,34,40] There 
have been only a few studies from German-speaking 
countries investigating the extent to which fetuses 
with congenital heart defects were actually detected 
in the course of general prenatal care and referred 
to a perinatal/pediatric cardiology center for further 
investigation, counselling and treatment planning.[23,24,40]
The authors were entirely justifi ed in concluding 
from their sobering results, showing, for instance, only 
a 10% prenatal detection rate for congenital right heart 
defects, that crucial progress would be achievable only 
by a marked improvement in both the level of training 
and the technical equipment of all involved in prenatal 
screening for malformations. The fact that the tentative 
external diagnosis of a possible heart defect can be 
confi rmed in most fetuses investigated in regional 
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prenatal medical centers emphasizes the importance of 
primary detection during prenatal care.[18-20,23,24,33,35,36] In 
principle, the majority of congenital heart defects can 
already be diagnosed by prenatal echocardiography and 
the detection rate is 85%-95% at tertiary perinatal 
centers.[9-11,16-20,23,24, 35, 36, 44] Nevertheless, in a few cases, exact 
and complete diagnosis is only successful postpartum 
as all current methods of intrauterine imaging of 
cardiac defects have numerous limitations including 
susceptibility to interference from fetal movements 
and marked dependence on fetal position. Segments of 
the heart overlaid by bony fetal thorax, spine or limb 
structures or parts of the heart situated posteriorly with 
oligo- or anhydramnios cannot be imaged especially 
at an advanced stage of pregnancy because of the 
absence of "fetal acoustic window". A further limitation 
is suboptimal or incomplete imaging of fetal heart 
segments with an extensive maternal stand-off distance 
or unfavorable placental or amniotic fl uid conditions (e.g., 
deep intrauterine or deep intraabdominal fetal position).
Physicians specializing in pre- and perinatal 
medicine, neonatology, pediatric cardiology and 
pediatric cardiac surgery are confronted almost 
daily in their clinical practice with lack of clarity in 
prenatal cardiac diagnosis. Despite all these long-
familiar limitations, early prenatal detection of heart 
defects makes a crucial contribution to optimizing 
prenatal and perinatal management. It involves detailed 
interdisciplinary counselling of the parents, possibly 
prenatal chromosome testing, ultrasound exclusion of 
extracardiac malformations, selection of the place and 
time of delivery in a perinatal or pediatric cardiology 
center and the ensurance of immediate interventions 
for critical heart lesions. Prenatal establishment 
of a cardiac defect on its own without pediatric 
cardiological/pediatric cardiac surgical counselling 
about all aspects of pre- and postnatal prognosis and 
treatment options not only leads to considerable anxiety 
for the parents but also may jeopardize the continuation 
of pregnancy in individual cases.
In utero progression of congenital heart 
defects
Postnatal pediatric cardiology studies have shown that 
only a few heart defects improve or heal spontaneously 
over time without intervention (e.g., spontaneous 
closure of muscular ventricular septal defects). In 
contrast, the majority of complex congenital lesions 
show a steadily progressive course including subsequent 
secondary phenomena such as arrhythmias or 
myocardial insuffi ciency. With valve stenosis/atresia 
diagnosed early, an increase in ventricular remodelling 
(sometimes irreversible endo- and/or myocardial 
secondary damage of the fetal heart) is often already 
apparent in utero. Moreover, the reduction in blood 
fl ow because of high-grade valve stenosis/atresia in the 
vascular bed downstream leads to diminished and often 
asymmetrical vessel growth with secondary (congenital) 
vessel hypoplasia. Since the early days of prenatal 
echocardiography diagnosis, innumerable reports 
have been published about intrauterine progression 
and increased abortion and stillbirth rates in fetuses 
with heart defects.[2,5,6,18,25,27,30,32,37,45,46] In the postnatal 
pediatric cardiological/pediatric cardiac surgery, it would 
be crucially important in the prenatal situation not only 
to diagnose cardiac defects as early as possible but also 
to treat them, thus avoiding secondary irreversible organ 
damage.[46] However, the corresponding cardiac structures 
of the fetus are accessible to many diagnostic and 
therapeutic procedures only at a more advanced gestational 
age (after the 18th week of pregnancy). With most cardiac 
defects, however, the organ damage is already considerable 
at the time of prenatal diagnosis and can no longer be 
corrected even by an intrauterine procedure.
Minimally invasive fetal therapy
Prenatal treatment of an abnormal fetus is an 
area of perinatal medicine that is undergoing a 
very dynamic development. Because of the rapid 
miniaturization of many endoscopes and cannula 
systems, an increasing number of fetal diseases that 
progress in utero are becoming accessible to prenatal 
treatment.[1,7,27,30,31,37,39,43,45-48]
For instance, with the aid of fetoscopically 
monitored laser coagulation, it is possible to interrupt 
communicating vascular anastomoses in the placenta in 
twin-to-twin transfusion syndrome.[7,33,47,48] Experience 
with more extensive fetoscopic procedures on the fetus 
such as temporary in utero palliation of diaphragmatic 
hernias, myelomeningoceles or distal urinary tract 
obstruction is currently limited to a few centers in the 
world. The sometimes much milder secondary damage 
reported in these fetuses sounds hopeful although these 
experimental methods have not become part of routine 
care to date because of lack of long-term results with 
regard to comprehensive postnatal pediatric surgical/
pediatric urological/neurosurgical expertise.[1,15,33,39,47,48] 
In keeping with the "early correction" aims of modern 
postnatal pediatric cardiac surgery, a few prenatal 
cardiac interventions were even performed on human 
fetuses.[6,14,18,19,27,37,45] Up to now, ultrasound-guided 
transabdominal or transthoracic puncture of the 
fetal heart in order to introduce a dilating catheter, 
which was then advanced into the stenotic valve, has 
been predominantly favored. Of the fi rst 13 fetuses 
with so-called critical aortic valve stenosis, in whom 
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such an intrauterine intervention was performed and 
analysed worldwide, only 1 fetus has survived a long-
term.[28,29,37,39] More recent follow-up studies, some still 
ongoing, appear to show a higher success and a higher 
survival rate.[6,27,45]
Unanswered questions
Apart from the technical diffi culties, a series of 
questions must be discussed in connection with the 
optimal outcome in fetuses with heart defects that are 
progressive while still in utero. The natural course 
of heart defects detected in utero requires further 
intensive study as stabilization or lack of progression 
in the prenatal situation can be described for some of 
these defects with modifi ed outcome analysis so that 
caution is warranted with any intrauterine procedures 
that might cause premature birth compared to the 
lower-risk postnatal operations.[5,6,12-14,25-27,30,32,37,42,45,46,48] 
The possibly favorable prognostic infl uence on the 
patients of bringing forward the timing of these 
techniques must be confi rmed in the next few years 
by well-designed studies. Fetuses with pulmonary 
valve atresia and postpartum catheter intervention can 
demonstrate a marked increase in right-ventricular 
dimensions including the possibility of biventricular 
palliation. Careful and suffi ciently long pre- and 
postnatal documentation of individual cases together 
with collection and analysis of data in international 
registers is crucial. It is only by coordinating the 
efforts of selected national and international centers 
that scientifi cally confi rmed progress in this area of 
interventional perinatal medicine can be expected.
Conclusion
In the not too distant future, the earlier interventions 
presented in this review article will supplement the 
known conventional postnatal treatment modalities 
available for a few of the cardiac defects that follow a 
progressive prenatal course. For physicians working 
in the area of pre- and perinatal medicine, it will 
therefore become increasingly diffi cult in the coming 
next years to give correct advice on procedures when 
these pregnant women are referred to them. To assist 
in decision-making, evaluation studies must urgently 
be initiated in centers specializing in the diagnosis and 
treatment of infants with heart disease. However, there 
is a particular requirement for the interdisciplinary 
counselling and psychological support of parents 
before, during and after the treatment. Comprehensive 
information about the nature of the disease and 
the probable prognosis depending on the time of 
treatment including all intervention-related risks must 
be provided by a consortium of prenatal physicians, 
pediatric cardiologists and cardiac surgeons. Otherwise, 
scientifi c medicine would be open to the reproach that 
it is further infl ating the interdisciplinary diagnosis and 
treatment apparatus without suffi ciently validating it or 
making it patient-oriented.
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